Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial

INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a viral respiratory syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This novel virus was discovered in Wuhan City, Hubei Province, China, in December 2019. As of September 6, 2020, confirmed cases have risen to mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Danyal, Dulipsingh, Latha, Zapatka, Lisa, Eadie, Reginald, Crowell, Rebecca, Williams, Kendra, Wakefield, Dorothy B., Cook, Lisa, Puff, Jennifer, Hussain, Syed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502154/
https://www.ncbi.nlm.nih.gov/pubmed/32951151
http://dx.doi.org/10.1007/s40121-020-00341-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502154/
https://www.ncbi.nlm.nih.gov/pubmed/32951151
http://dx.doi.org/10.1007/s40121-020-00341-2

Ejemplares similares